Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Dr. David Maloney discussed advances in cell therapies and what it means for blood cancer patients.
In a Q&A about her position as ASH president, Dr. Stephanie Lee encouraged others to pursue leadership roles.
Dr. Trevor Bedford confirmed his assessment that scientific evidence shows the 614G variant of SARS-CoV-2 is more easily transmitted.
Dr. Holly Janes discussed the importance of large clinical trials for assessing safety of vaccine candidates.
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
Dr. Trevor Bedford predicted that U.S. COVID-19 deaths could reach 2,000 a day within weeks, and that “Importantly, this doesn’t assume any further increases in circulation and is essentially ‘baked into’ currently reported cases.”
Dr. Laura Matrajt discussed how her computer modeling studies on vaccine distribution strategies have adapted with the pandemic.
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Dr. Soheil Meshinchi discussed how computational tools are revealing how to best match cancer therapies for patients.
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area.
The New York Times magazine’s “Studies Show” featured Dr. Laura Matrajt’s vaccine modeling preprint paper.
GeekWire detailed the cancer research projects within the Fred Hutch-led Cascadia Data Alliance.